Afghanistan vs Turkmenistan: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Afghanistan
0.3%
in 2024
Turkmenistan
0.3%
in 2024
Afghanistan rank
85th
Turkmenistan rank
85th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Afghanistan
- Turkmenistan
How they compare
Afghanistan currently reports 0.3% against 0.3% in Turkmenistan, a difference of 0.0%.
Across all 10 years both countries report, Turkmenistan has been ahead every year.
Afghanistan ranks 85th and Turkmenistan ranks 85th of 246 countries.
Turkmenistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Afghanistan | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.4% | 0.1% | Turkmenistan |
| 2020s | 0.3% | 0.3% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Afghanistan or Turkmenistan?
- Afghanistan, at 0.3% against 0.3% in Turkmenistan as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Afghanistan and Turkmenistan?
- 0.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Turkmenistan?
- 10 years are reported by both, from 2015 to 2024.
- How do Afghanistan and Turkmenistan rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Afghanistan ranks 85th and Turkmenistan ranks 85th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.